Clin2

Otolaryngology

Ear, nose & throat clinical trials

Hearing, balance, and conditions of the ears, nose, sinuses, and throat. We’re tracking 1,273 recruiting studies in this area right now.

1,273
Recruiting now
2,079
Studies tracked
≈1.4M
Enrollment sought

By phase

  • Not applicable891
  • Phase 2156
  • Phase 3103
  • Phase 148
  • Phase 431
  • Phase 1/Phase 230
  • Phase 2/Phase 314

Top conditions

Leading sponsors

  • Sun Yat-sen University57
  • Assistance Publique - Hôpitaux de Paris14
  • Eye & ENT Hospital of Fudan University14
  • National Cancer Institute (NCI)14
  • Cairo University13
  • NYU Langone Health13
  • Mayo Clinic12
  • Johns Hopkins University11
  • Ming-Yuan Chen11
  • Massachusetts Eye and Ear Infirmary10

Where studies are running

  • California61
  • Maryland38
  • Florida32
  • New York32
  • Massachusetts24
  • Illinois20
  • Texas20
  • Alabama15
  • Arizona15
  • Colorado15

Recruiting studies1,273 total

Page 53 of 54

Common questions

How many ear, nose & throat clinical trials are recruiting?
Clin2 is tracking 1,273 recruiting otolaryngology studies from the U.S. registry right now, out of 2,079 we cover in this area in total.
What does “Ear, nose & throat” cover here?
Hearing, balance, and conditions of the ears, nose, sinuses, and throat. We group each study into ear, nose & throat based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
How do I find a ear, nose & throat trial near me?
Use the search to filter ear, nose & throat studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.

Other specialties

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.